Effect of mangiferin on muscle GLUT4 protein content in TSOD (Tsumura, Suzuki, Obese, Diabetes) mouse, a new type 2 diabetic mice

Biomedical Research

Volumn 22, Issue 5, 2001, Pages 249-252

  Miura, Toshihiro ^a   Iwamoto, Naoki ^a   Kato, Motoshi ^a   Ichiki, Hiroyuki ^b   Kubo, Masayoshi ^b   Komatsu, Yasuhiro ^b   Sasaki, Hiroshi ^b   Ishida, Torao ^a   Tanigawa, Keiichiro ^a  

^a SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b TSUMURA AND CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; ISOPROTEIN; MANGIFERIN; MUSCLE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MOUSE; MOUSE STRAIN; MUSCLE FIBER MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN CONTENT;

ANIMALIA;

EID: 0041296002     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.22.249     Document Type: Article

References (26)

1. Bailei C. J., Ahmed-Sorour H. (1980) Role of ovarian hormones in the long-term control of glucose homeostasis. Diabetologia 19: 475-481.
2. Baron A., Zhu J. S., Zhu J. H., Weldon H., Maianu L., Garvey M. T. (1995) Glucosamine induces insulin resistance in vivo by affecting GLUT4 translocation in skeletal muscle. Implications for glucose toxicity. J. Clin. Invest. 97: 2792-2801.
3. Bell G. I., Kayano T., Buse J. B., Burant C. F., Takeda J., Lin D., Fukumoto H., Seino S. (1990) Molecular biology of mammalian glucose transporters. Diabetes Care 13: 198-208.
4. Berger J., Biswas C., Vicario P. P., Strout H. V., Seperstein R., Pilch P. F. (1989) Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340: 70-72.
5. Coleman D. L. (1982) Diabetes-obesity syndromes in mice. Diabetes 31 (Suppl. 1): 1-6.
6. Fujita M., Inoue T. (1982) Studies on the constituents of Iris florentina L. C-glucosides Xanthones and Flavones from the leaves. Chem. Pharm. Bull., 30, 2342-2348.
7. Hirayama I., Yi Z., Izumi S., Arai I., Suzuki W., Nagamachi Y., Kuwano H., Takeuchi T., Izumi T. (1999) Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 48, 1183-1191.
8. Ichiki H., Miura T., Kubo M., Ishihara E., Komatsu Y., Okada M., Tanigawa K. (1998) New antidiabetic compounds, mangiferin and its glucoside. Biol. Pharm. Bull., 21, 1389-1390.
9. Iwamoto N., Miura T., Kato M., Takemoto T., Ichiki H., Kubo M., Komatsu Y., Ishihara E., Sasaki H., Ishida T., Seino Y., Tanigawa K. (2000) Effect of mangiferin with exercise in early stage symptom of type 2 diabetic mice. Biomed. Res., 21, 221-223.
10. James D. E., Strube M., Mueckler M. (1989) Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83-87.
11. Klip A., Ramlal T., Young D. A., Holloszy J. O. (1987) Insulin-stimulated glucose transporters in rat hindlimb muscles. FEBS Lett. 224: 224-230.
12. Klip A., Ramlal T., Bilan P. J., Cartee G. D., Gulve E. A., Holloszy J. O. (1990) Recruitment of GLUT4 glucose transporter by insulin in diabetic rat skeletal muscle. Biochem. Biophys. Res. Commun. 172: 728-736.
13. Masuda K., Okamoto Y., Tsuura Y., Kato S., Miura T., Tsuda K., Hosikoshi H., Ishida H., Seino Y. (1995) Effect of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islet and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia, 38, 34-30.
14. Miura T., Ichiki H., Hashimoto I., Iwamoto N., Kato M., Kubo M., Ishihara E., Komatsu Y., Okada M., Ishida T., Tanigawa K. (2001) Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine, 8, 85-87.
15. Miura T., Fukuta C., Ichiki H., Iwamoto N., Kato M., Kubo M., Komatsu Y., Ishida T., Okada M., Tanigawa K. (2001) Hypolipidemic activity of mangiferin in cholesterol-fed mice. J. Trad. Medcines, 18, 119-121.
16. Nakamura M. (1962) A diabetic strain of the mouse. Proc. Jpn. Acad. 38: 348-352.
17. Nishimura M. (1969) Breeding of mice strains for diabetes mellitus. Exp. Animal 18: 147-157.
18. Oka Y., Asano T., Shibasaki A. (1990) Increased liver glucose transporter protein and mRNA in streptozotocin-induced diabetic mice. Diabetes 39: 441-446.
19. Coleman D. L. (1982) Diabetes-obesity syndromes in mice. Diabetes 31 (Suppl. 1): 1-6.
20. Perez C., Albert I., DeFay K. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251-258.
21. Simpson I. A., Cushman S. W. (1986) Hormonal regulation of mammalian glucose transport. Ann. Rev. Biochem. 55: 1059-1089.
22. Sivitz W. I., Desautel S. L., Kayano T., Bell G. I., Pessin J. E. (1989) Regulation of glucose transporter messenger RNA in insulin-deficient states. Nature 340: 72-74.
23. Stevens J. F. (1951) Determination of blood glucose by glucose oxidase method. Clin. Chim. Acta. 32: 199-201.
24. Suzuki J., and Kimura M (1993) Hypoglycemic effect of the blended Chinese traditional medicines in genetically and chemically diabetic mice. Folia Pharmacol. Japon, 83, 1-10.
25. Suzuki W., Iizuka S., Tabuchi M., Funo S., Yanagisawa T., Kimura M., Sato T., Endo T., Kawamura H. (1999) A new mouse model of spontaneous diabetes derived from ddY strain. Exp. Anim., 48, 181-189.
26. Wheeler T. J., Hinkle P. C. (1985) The glucose transporter of mammalian cells. Ann. Rev. Physiol. 47: 503-517.